Tajikistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Health News.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on January 30, 2026

Jan. 30, 2026

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

GlobeNewswire

Jan. 30, 2026

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

GlobeNewswire

Jan. 30, 2026

NEOMED earns accreditation for new Certified Mental Health Assistant program and becomes first in the nation to offer the innovative degree

GlobeNewswire

Jan. 30, 2026

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

GlobeNewswire

Jan. 30, 2026

Crescent Biopharma Announces Grants of Inducement Awards

GlobeNewswire

Jan. 30, 2026

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

GlobeNewswire

Jan. 30, 2026

NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise

GlobeNewswire

Jan. 30, 2026

Olema Oncology Announces Departure of Chief Operating and Financial Officer

GlobeNewswire

Jan. 30, 2026

Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders

GlobeNewswire

Jan. 30, 2026

Dr. Christina Rahm and Clayton Thomas of The ROOT Brands Attend World Economic Forum Annual Meeting 2026 in Davos

GlobeNewswire

Jan. 30, 2026

CrazyBulk: SARM Alternatives for Bulking, Strength and Performance or Just Hype?

GlobeNewswire

Jan. 30, 2026

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma

GlobeNewswire

Jan. 30, 2026

Global Virus Network Statement on Nipah Virus Outbreak

GlobeNewswire

Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

GlobeNewswire

Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

GlobeNewswire

Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU

GlobeNewswire

Jan. 30, 2026

Global Drug Device Combination Products Market to Reach USD 379.17 Billion by 2030 | MarketsandMarkets™

GlobeNewswire

Jan. 30, 2026

Standard BioTools Completes Sale of SomaLogic to Illumina

GlobeNewswire

Jan. 30, 2026

Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets

GlobeNewswire

Jan. 30, 2026

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

GlobeNewswire